Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bonneterre

Showing results (101-110 of 194) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|March 11, 1995
Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancerJ P Peyrat, J Bonneterre, R Lubin, et al.
American Journal of Clinical Oncology|April 1, 1995
Cytarabine and cisplatin as salvage therapy in patients with metastatic colorectal cancer who failed 5-fluorouracil + folinic acid regimen. French Northern Oncology GroupA Adenis, D Carlier, F Darloy, et al.
Bulletin Du Cancer|January 1, 1992
[A study of VMMC protocol (vindesine, mitoxantrone, mitomycin C) as a salvage chemotherapy in advanced breast cancers]M Degardin, B Hecquet, J Bonneterre, et al.
Breast Cancer Research and Treatment|January 1, 1985
Estradiol and progesterone receptors in breast cancer: prognostic value after relapseJ Bonneterre, D Horner, J P Peyrat, et al.
Bulletin Du Cancer|February 10, 1999
[Adjuvant treatment of cancer of the breast: cost assessment of the protocol used]B Selke, C Bercez, X Lenne, et al.
Bulletin Du Cancer|February 1, 1993
[Surgery of breast cancer and date of last menstruation]P Vennin, J P Peyrat, J Bonneterre, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 10, 2015
[Systemic treatment of brain metastases from breast cancer]S Taillibert, R Conforti, J Bonneterre, et al.
Cancer Chemotherapy and Pharmacology|November 3, 2011
A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanesM Campone, N Isambert, E Bourbouloux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patientsM Hebbar, F Révillion, M M Louchez, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1982
Prolactin receptors in human breast cancerJ Bonneterre, J P Peyrat, B Vandewalle, et al.
Pageof 20

Showing results (101-110 of 194) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|March 11, 1995
Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancerJ P Peyrat, J Bonneterre, R Lubin, et al.
American Journal of Clinical Oncology|April 1, 1995
Cytarabine and cisplatin as salvage therapy in patients with metastatic colorectal cancer who failed 5-fluorouracil + folinic acid regimen. French Northern Oncology GroupA Adenis, D Carlier, F Darloy, et al.
Bulletin Du Cancer|January 1, 1992
[A study of VMMC protocol (vindesine, mitoxantrone, mitomycin C) as a salvage chemotherapy in advanced breast cancers]M Degardin, B Hecquet, J Bonneterre, et al.
Breast Cancer Research and Treatment|January 1, 1985
Estradiol and progesterone receptors in breast cancer: prognostic value after relapseJ Bonneterre, D Horner, J P Peyrat, et al.
Bulletin Du Cancer|February 10, 1999
[Adjuvant treatment of cancer of the breast: cost assessment of the protocol used]B Selke, C Bercez, X Lenne, et al.
Bulletin Du Cancer|February 1, 1993
[Surgery of breast cancer and date of last menstruation]P Vennin, J P Peyrat, J Bonneterre, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 10, 2015
[Systemic treatment of brain metastases from breast cancer]S Taillibert, R Conforti, J Bonneterre, et al.
Cancer Chemotherapy and Pharmacology|November 3, 2011
A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanesM Campone, N Isambert, E Bourbouloux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patientsM Hebbar, F Révillion, M M Louchez, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1982
Prolactin receptors in human breast cancerJ Bonneterre, J P Peyrat, B Vandewalle, et al.
Pageof 20